HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Bridgefront Capital, LLC's Holding History (CIK: 0001725690)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 6,815 Value ($000) $500 Avg Close $66.43 Range $51.78 - $79.50

Q2 2025

Shares 6,520 Value ($000) $339 Avg Close $56.90 Range $47.50 - $70.51

Q3 2023

Shares 6,238 Value ($000) $238 Avg Close $40.96 Range $35.71 - $45.00

Q2 2021

Shares 9,230 Value ($000) $419 Avg Close $44.26 Range $38.65 - $51.57

Q1 2021

Shares 5,088 Value ($000) $212 Avg Close $45.65 Range $38.80 - $56.40

Q4 2020

Shares 12,004 Value ($000) $513 Avg Close $35.95 Range $25.70 - $44.53

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	6,815	$500	$66.43	$51.78 - $79.50
Q2 2025	6,520	$339	$56.90	$47.50 - $70.51
Q3 2023	6,238	$238	$40.96	$35.71 - $45.00
Q2 2021	9,230	$419	$44.26	$38.65 - $51.57
Q1 2021	5,088	$212	$45.65	$38.80 - $56.40
Q4 2020	12,004	$513	$35.95	$25.70 - $44.53